Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Amlenetug by H. Lundbeck for Parkinson's Disease: Likelihood of Approval
Amlenetug is under clinical development by H. Lundbeck and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase...